Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Follow the firms, the rounds and the people behind them.
Firms, funds, rounds and the people behind them, read from filings and announcements. Free to read, with the source and the date on every row.
What are you trying to do?
Who is funding what, who co-invests with whom, and which firms are active right now.
- Firms and funds
- Co-investor pairs
- Rounds on the record
The firms that actually write cheques at your stage, and the partners who lead them.
- Firms by observed activity
- Partners and their deals
- Who already funded your sector
Fund filings, limited partners on the record and what peers of your size have closed.
- Funds and filings
- Limited partners
- Peer closings
Or keep reading. Everything below is public, and picking a door only changes what leads.
Search by what an investor has done, not what its website says
Every organization here entered through a public record: a Form ADV filing that claims the venture capital fund adviser exemption or reports venture funds, a Form D venture vehicle, a portfolio page, or a cited announcement. The class chip says what kind of organization it is and how sure we are; the profile says why. Candidates are shown as candidates and are not counted as coverage.
Pappas Capital is among the Top Healthcare Venture Capital Firms, focused on advancing biopharma, biotech, and medical technologies that improve patient outcomes.
corporate parent: P10 Holdings, Inc.
venture manager, reported GAV $384M across 8 vehicles
WSC & Company is a private investment firm acquiring businesses nationwide alongside exceptional entrepreneurs.
One firm, 2 filing advisers on echohealthventures.com · Echo Health Ventures
Echo Health Ventures invests to build and grow great health care companies.
Hatteras Venture Partners is a healthcare venture capital firm investing in biotech, medtech, and healthtech companies advancing patient care.
registered adviser; venture funds are 0% of 9 private funds
Plexus is a provider of capital for the lower middle market; one team with tailored capital for the opportunity.
100% satisfaction guaranteed on every domain we sell. 30-day, no questions asked, money-back guarantee. Easy, fast and convenient shopping.
venture manager, reported GAV $39.9M across 7 vehicles
both early and growth/opportunity families, reported GAV $93M
Thesis. Exploration. Breakthrough. We employ a theme-based approach to identify uniquely differentiated businesses in durable growth markets.
Kineticos provides expertise, deep industry knowledge, and proven experts to their life sciences portfolio companies.
A seed and early-stage venture firm partnering with entrepreneurs on B2B healthcare software and tech-enabled services.
venture manager, reported GAV $108M across 5 vehicles
venture manager, reported GAV $102M across 2 vehicles
Fundamental Global partners with visionary founders to invest in, build, and scale groundbreaking companies from inception to public listings on the Nasdaq and NYSE
venture manager, reported GAV $5.1M across 1 vehicles
venture manager, reported GAV $3.9M across 2 vehicles
Dental Innovation Alliance (DIA) is an organization of some of the country’s most successful and influential dental leaders who collectively fund, advise, connect and propel the success of early-stage dental technology companies.
The first venture firm with access to 100M+ engaged consumers across the world.
venture manager, reported GAV $5.4M across 3 vehicles
One firm, 2 filing advisers on hatterasfunds.com · Hatteras Investment Partners
Hatteras Investment Partners helps RIAs, Family Offices, and Investment Consultants differentiate themselves from competitors to reach more qualified clients.
The record above stays free. What you pay for is the depth behind it.
Free to read. $199 a month to work in.
The full comparisonNo account. What a visitor and a search engine both see.
- Every entity by name, with its type and its record
- The dated public tape: what changed and when
- The source and the date on every published row
- The methodology, in full
Enough to be useful on its own, and it is how we learn what you came for.
- Follow entities and get a weekly digest of what moved
- Save searches and keep one universe
- A small monthly reveal allowance, to see what a contact looks like
- A small export, with its source column
or 10 months paid yearly. The working tier: the depth and the reach behind every lock on this vertical.
- Reveal the published contact line, with its source
- The whole change history on any record, back to first seen
- Every filter, across the whole record rather than the first page
- CSV export with the source column intact
- 250 follows, 25 saved screens, 5 universes
For the people who work this market every day rather than look things up in it.
- Alerts the day something moves, on an entity, a screen or a universe
- Continuous monitoring with a daily digest
- Exports at the size you actually load into a CRM
- A reveal allowance for a working desk, not a sample
- 2,000 follows, 100 saved screens, 25 universes
All nine verticals, and the joins between them. The one thing here that no list you can buy anywhere else contains.
- Every vertical, at Pro depth
- The same entity across all nine graphs, joined on identity
- Cross-graph search, universes and alerts
- One invoice instead of a collection of subscriptions
The family offices behind the LP line in these funds.
$249 / month
Where these companies go after venture.
$249 / month
The institutions that commit to funds at this stage.
$299 / month
Each is its own subscription. Three or more and the whole Factory costs less, at $599 a month for all nine.
Every row on this page carries its source and its date. The methodology says what is measured, what is inferred, and what DFX does not claim. The Data Factory is this and eight other graphs, joined.